nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—CALM2—gall bladder—bile duct cancer	0.000286	0.0783	CbGeAlD
Nicardipine—CACNA1D—pancreas—bile duct cancer	0.000217	0.0594	CbGeAlD
Nicardipine—PDE1A—liver—bile duct cancer	0.000214	0.0587	CbGeAlD
Nicardipine—PDE1B—lymph node—bile duct cancer	0.000196	0.0537	CbGeAlD
Nicardipine—CALM1—Signaling Pathways—TGFBR2—bile duct cancer	0.000175	0.000176	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—GNAS—bile duct cancer	0.000175	0.000175	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—KRAS—bile duct cancer	0.000173	0.000174	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SMAD4—bile duct cancer	0.000172	0.000172	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—TGFB1—bile duct cancer	0.000171	0.000172	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—EGFR—bile duct cancer	0.000171	0.000172	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—EGFR—bile duct cancer	0.000171	0.000172	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—ERBB2—bile duct cancer	0.000171	0.000171	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—KRAS—bile duct cancer	0.00017	0.000171	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—EGFR—bile duct cancer	0.00017	0.00017	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—GNAS—bile duct cancer	0.000169	0.00017	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—GNAS—bile duct cancer	0.000169	0.00017	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—EGFR—bile duct cancer	0.000168	0.000168	CbGpPWpGaD
Nicardipine—CALM3—pancreas—bile duct cancer	0.000168	0.0459	CbGeAlD
Nicardipine—CALM3—Innate Immune System—KRAS—bile duct cancer	0.000167	0.000168	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SMAD4—bile duct cancer	0.000166	0.000167	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SMAD4—bile duct cancer	0.000166	0.000167	CbGpPWpGaD
Nicardipine—CALM3—Hemostasis—TP53—bile duct cancer	0.000165	0.000165	CbGpPWpGaD
Nicardipine—PDE1A—lymph node—bile duct cancer	0.000164	0.045	CbGeAlD
Nicardipine—ADRA1B—Signaling by GPCR—NRAS—bile duct cancer	0.000164	0.000165	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—EGFR—bile duct cancer	0.000164	0.000165	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—EGFR—bile duct cancer	0.000164	0.000165	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—ERBB2—bile duct cancer	0.000163	0.000164	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—GNAS—bile duct cancer	0.000162	0.000163	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—KRAS—bile duct cancer	0.000162	0.000162	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—KRAS—bile duct cancer	0.000162	0.000162	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—HRAS—bile duct cancer	0.000161	0.000161	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—KRAS—bile duct cancer	0.00016	0.000161	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—TP53—bile duct cancer	0.000159	0.00016	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—TP53—bile duct cancer	0.000159	0.00016	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—KRAS—bile duct cancer	0.000159	0.000159	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—GNAS—bile duct cancer	0.000158	0.000159	CbGpPWpGaD
Nicardipine—CACNB2—liver—bile duct cancer	0.000158	0.0433	CbGeAlD
Nicardipine—CALM3—Hemostasis—HRAS—bile duct cancer	0.000158	0.000158	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—KRAS—bile duct cancer	0.000155	0.000156	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—KRAS—bile duct cancer	0.000155	0.000156	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—TP53—bile duct cancer	0.000154	0.000155	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—HRAS—bile duct cancer	0.000154	0.000155	CbGpPWpGaD
Nicardipine—CHRM4—Signaling by GPCR—IL6—bile duct cancer	0.000154	0.000154	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—ERBB2—bile duct cancer	0.000154	0.000154	CbGpPWpGaD
Nicardipine—CALM1—Hemostasis—HRAS—bile duct cancer	0.000152	0.000153	CbGpPWpGaD
Nicardipine—CALM2—Hemostasis—HRAS—bile duct cancer	0.000152	0.000153	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—EGFR—bile duct cancer	0.00015	0.00015	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—GNAS—bile duct cancer	0.000149	0.00015	CbGpPWpGaD
Nicardipine—CALM3—Immune System—ERBB2—bile duct cancer	0.000149	0.000149	CbGpPWpGaD
Nicardipine—CACNA2D1—liver—bile duct cancer	0.000148	0.0406	CbGeAlD
Nicardipine—CHRM1—Signaling by GPCR—NRAS—bile duct cancer	0.000148	0.000149	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—GNAS—bile duct cancer	0.000148	0.000149	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—NRAS—bile duct cancer	0.000148	0.000148	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—HRAS—bile duct cancer	0.000147	0.000148	CbGpPWpGaD
Nicardipine—CHRM5—Signaling by GPCR—IL6—bile duct cancer	0.000147	0.000148	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—MMP9—bile duct cancer	0.000146	0.000147	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—NRAS—bile duct cancer	0.000146	0.000147	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—NRAS—bile duct cancer	0.000146	0.000146	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—HRAS—bile duct cancer	0.000145	0.000145	CbGpPWpGaD
Nicardipine—CALM1—Immune System—ERBB2—bile duct cancer	0.000144	0.000144	CbGpPWpGaD
Nicardipine—CALM2—Immune System—ERBB2—bile duct cancer	0.000144	0.000144	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—HRAS—bile duct cancer	0.000142	0.000142	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—KRAS—bile duct cancer	0.000141	0.000142	CbGpPWpGaD
Nicardipine—PDE1A—Signaling Pathways—IL6—bile duct cancer	0.000141	0.000142	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—TP53—bile duct cancer	0.000141	0.000141	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—MMP9—bile duct cancer	0.00014	0.000141	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling by GPCR—IL6—bile duct cancer	0.000139	0.000139	CbGpPWpGaD
Nicardipine—CACNA1D—liver—bile duct cancer	0.000138	0.0378	CbGeAlD
Nicardipine—CALM1—Innate Immune System—HRAS—bile duct cancer	0.000137	0.000138	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—HRAS—bile duct cancer	0.000137	0.000138	CbGpPWpGaD
Nicardipine—CALM3—Disease—ERBB2—bile duct cancer	0.000137	0.000138	CbGpPWpGaD
Nicardipine—CALM3—Adaptive Immune System—HRAS—bile duct cancer	0.000136	0.000137	CbGpPWpGaD
Nicardipine—CALM3—Innate Immune System—IL6—bile duct cancer	0.000136	0.000136	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—EGFR—bile duct cancer	0.000135	0.000135	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—HRAS—bile duct cancer	0.000135	0.000135	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—EGFR—bile duct cancer	0.000135	0.000135	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PTGS2—bile duct cancer	0.000134	0.000135	CbGpPWpGaD
Nicardipine—CALM3—Disease—PTGS2—bile duct cancer	0.000134	0.000135	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—EGFR—bile duct cancer	0.000133	0.000134	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—EGFR—bile duct cancer	0.000133	0.000133	CbGpPWpGaD
Nicardipine—CALM2—Disease—ERBB2—bile duct cancer	0.000133	0.000133	CbGpPWpGaD
Nicardipine—CALM1—Disease—ERBB2—bile duct cancer	0.000133	0.000133	CbGpPWpGaD
Nicardipine—CALM1—Adaptive Immune System—HRAS—bile duct cancer	0.000132	0.000132	CbGpPWpGaD
Nicardipine—CALM2—Adaptive Immune System—HRAS—bile duct cancer	0.000132	0.000132	CbGpPWpGaD
Nicardipine—CALM2—pancreas—bile duct cancer	0.000132	0.0361	CbGeAlD
Nicardipine—ADRA1D—Signaling Pathways—MMP9—bile duct cancer	0.000132	0.000132	CbGpPWpGaD
Nicardipine—CALM2—Innate Immune System—IL6—bile duct cancer	0.000131	0.000132	CbGpPWpGaD
Nicardipine—CALM1—Innate Immune System—IL6—bile duct cancer	0.000131	0.000132	CbGpPWpGaD
Nicardipine—CALM1—pancreas—bile duct cancer	0.000131	0.0359	CbGeAlD
Nicardipine—CHRM4—Signaling Pathways—NRAS—bile duct cancer	0.00013	0.00013	CbGpPWpGaD
Nicardipine—CALM2—Disease—PTGS2—bile duct cancer	0.00013	0.00013	CbGpPWpGaD
Nicardipine—CALM1—Disease—PTGS2—bile duct cancer	0.00013	0.00013	CbGpPWpGaD
Nicardipine—PDE1B—Signaling Pathways—IL6—bile duct cancer	0.000129	0.000129	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—KRAS—bile duct cancer	0.000128	0.000128	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—ERBB2—bile duct cancer	0.000128	0.000128	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—KRAS—bile duct cancer	0.000127	0.000128	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—KRAS—bile duct cancer	0.000126	0.000126	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—SLC5A5—bile duct cancer	0.000126	0.000126	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—KRAS—bile duct cancer	0.000126	0.000126	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—NRAS—bile duct cancer	0.000124	0.000125	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—NRAS—bile duct cancer	0.000124	0.000124	CbGpPWpGaD
Nicardipine—CACNB2—lymph node—bile duct cancer	0.000121	0.0332	CbGeAlD
Nicardipine—CHRM4—Signaling Pathways—TGFB1—bile duct cancer	0.000121	0.000121	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—HRAS—bile duct cancer	0.00012	0.000121	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—NRAS—bile duct cancer	0.00012	0.00012	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—NRAS—bile duct cancer	0.00012	0.00012	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—EGFR—bile duct cancer	0.000118	0.000119	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—NRAS—bile duct cancer	0.000117	0.000117	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TGFB1—bile duct cancer	0.000116	0.000116	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PTGS2—bile duct cancer	0.000115	0.000116	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—ERBB2—bile duct cancer	0.000115	0.000115	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—IL6—bile duct cancer	0.000115	0.000115	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—ERBB2—bile duct cancer	0.000115	0.000115	CbGpPWpGaD
Nicardipine—CACNA2D1—lymph node—bile duct cancer	0.000114	0.0311	CbGeAlD
Nicardipine—CHRM2—Signaling Pathways—ERBB2—bile duct cancer	0.000114	0.000114	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—ERBB2—bile duct cancer	0.000113	0.000114	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—EGFR—bile duct cancer	0.000113	0.000114	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PTGS2—bile duct cancer	0.000113	0.000113	CbGpPWpGaD
Nicardipine—CALM3—Immune System—NRAS—bile duct cancer	0.000113	0.000113	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PTGS2—bile duct cancer	0.000113	0.000113	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—EGFR—bile duct cancer	0.000113	0.000113	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PTGS2—bile duct cancer	0.000112	0.000113	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—KRAS—bile duct cancer	0.000112	0.000112	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MMP9—bile duct cancer	0.000109	0.00011	CbGpPWpGaD
Nicardipine—CALM2—Immune System—NRAS—bile duct cancer	0.000109	0.00011	CbGpPWpGaD
Nicardipine—CALM1—Immune System—NRAS—bile duct cancer	0.000109	0.00011	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—EGFR—bile duct cancer	0.000109	0.000109	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—EGFR—bile duct cancer	0.000109	0.000109	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PTGS2—bile duct cancer	0.000109	0.000109	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PTGS2—bile duct cancer	0.000109	0.000109	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TGFB1—bile duct cancer	0.000109	0.000109	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—HRAS—bile duct cancer	0.000108	0.000109	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—HRAS—bile duct cancer	0.000108	0.000108	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—HRAS—bile duct cancer	0.000107	0.000107	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—KRAS—bile duct cancer	0.000107	0.000107	CbGpPWpGaD
Nicardipine—CALM3—liver—bile duct cancer	0.000107	0.0292	CbGeAlD
Nicardipine—ADRA1A—Signaling by GPCR—HRAS—bile duct cancer	0.000107	0.000107	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—EGFR—bile duct cancer	0.000106	0.000107	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—KRAS—bile duct cancer	0.000106	0.000107	CbGpPWpGaD
Nicardipine—CACNA1D—lymph node—bile duct cancer	0.000106	0.029	CbGeAlD
Nicardipine—CALM3—Disease—NRAS—bile duct cancer	0.000104	0.000105	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—IL6—bile duct cancer	0.000104	0.000104	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—IL6—bile duct cancer	0.000103	0.000104	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—KRAS—bile duct cancer	0.000103	0.000103	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—KRAS—bile duct cancer	0.000103	0.000103	CbGpPWpGaD
Nicardipine—CALM3—Immune System—EGFR—bile duct cancer	0.000103	0.000103	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—IL6—bile duct cancer	0.000102	0.000103	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—IL6—bile duct cancer	0.000102	0.000103	CbGpPWpGaD
Nicardipine—CALM2—Disease—NRAS—bile duct cancer	0.000101	0.000101	CbGpPWpGaD
Nicardipine—CALM1—Disease—NRAS—bile duct cancer	0.000101	0.000101	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—KRAS—bile duct cancer	0.000101	0.000101	CbGpPWpGaD
Nicardipine—CALM1—Immune System—EGFR—bile duct cancer	9.96e-05	9.99e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—EGFR—bile duct cancer	9.96e-05	9.99e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—bile duct cancer	9.93e-05	9.97e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MMP9—bile duct cancer	9.87e-05	9.9e-05	CbGpPWpGaD
Nicardipine—CYP3A5—pancreas—bile duct cancer	9.86e-05	0.027	CbGeAlD
Nicardipine—CHRM3—Signaling Pathways—MMP9—bile duct cancer	9.84e-05	9.87e-05	CbGpPWpGaD
Nicardipine—CACNA1C—lymph node—bile duct cancer	9.78e-05	0.0268	CbGeAlD
Nicardipine—CYP2C8—Metabolism—PTGS2—bile duct cancer	9.77e-05	9.8e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—GNAS—bile duct cancer	9.76e-05	9.8e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MMP9—bile duct cancer	9.74e-05	9.78e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—KRAS—bile duct cancer	9.72e-05	9.76e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MMP9—bile duct cancer	9.72e-05	9.75e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—NRAS—bile duct cancer	9.7e-05	9.74e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—TGFB1—bile duct cancer	9.69e-05	9.73e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—ERBB2—bile duct cancer	9.6e-05	9.64e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—bile duct cancer	9.51e-05	9.54e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—EGFR—bile duct cancer	9.5e-05	9.54e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—HRAS—bile duct cancer	9.5e-05	9.53e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KRAS—bile duct cancer	9.41e-05	9.44e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KRAS—bile duct cancer	9.41e-05	9.44e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—TGFB1—bile duct cancer	9.38e-05	9.41e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—TGFB1—bile duct cancer	9.38e-05	9.41e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—ERBB2—bile duct cancer	9.29e-05	9.32e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—ERBB2—bile duct cancer	9.29e-05	9.32e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—bile duct cancer	9.19e-05	9.23e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—bile duct cancer	9.19e-05	9.23e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—HRAS—bile duct cancer	9.09e-05	9.13e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—IL6—bile duct cancer	9.09e-05	9.12e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—HRAS—bile duct cancer	9.05e-05	9.08e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TGFB1—bile duct cancer	9.01e-05	9.05e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—KRAS—bile duct cancer	8.98e-05	9.01e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—bile duct cancer	8.94e-05	8.97e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—bile duct cancer	8.84e-05	8.87e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NRAS—bile duct cancer	8.75e-05	8.79e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—HRAS—bile duct cancer	8.75e-05	8.78e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—HRAS—bile duct cancer	8.75e-05	8.78e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NRAS—bile duct cancer	8.73e-05	8.76e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—bile duct cancer	8.72e-05	8.75e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—IL6—bile duct cancer	8.7e-05	8.74e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—KRAS—bile duct cancer	8.69e-05	8.72e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—KRAS—bile duct cancer	8.69e-05	8.72e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—IL6—bile duct cancer	8.66e-05	8.69e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NRAS—bile duct cancer	8.64e-05	8.67e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NRAS—bile duct cancer	8.62e-05	8.65e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HRAS—bile duct cancer	8.55e-05	8.58e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—bile duct cancer	8.51e-05	8.54e-05	CbGpPWpGaD
Nicardipine—CALM2—liver—bile duct cancer	8.39e-05	0.023	CbGeAlD
Nicardipine—CALM2—Signaling by GPCR—IL6—bile duct cancer	8.38e-05	8.41e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—IL6—bile duct cancer	8.38e-05	8.41e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KRAS—bile duct cancer	8.35e-05	8.38e-05	CbGpPWpGaD
Nicardipine—CALM1—liver—bile duct cancer	8.35e-05	0.0228	CbGeAlD
Nicardipine—CALM3—Immune System—HRAS—bile duct cancer	8.27e-05	8.3e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MMP9—bile duct cancer	8.24e-05	8.27e-05	CbGpPWpGaD
Nicardipine—CALM3—lymph node—bile duct cancer	8.19e-05	0.0224	CbGeAlD
Nicardipine—ADRA1D—Signaling Pathways—IL6—bile duct cancer	8.18e-05	8.21e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TGFB1—bile duct cancer	8.13e-05	8.16e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TGFB1—bile duct cancer	8.11e-05	8.14e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TGFB1—bile duct cancer	8.03e-05	8.06e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—bile duct cancer	8.02e-05	8.05e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TGFB1—bile duct cancer	8.01e-05	8.04e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HRAS—bile duct cancer	8e-05	8.03e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HRAS—bile duct cancer	8e-05	8.03e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—bile duct cancer	7.97e-05	8e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MMP9—bile duct cancer	7.97e-05	8e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MMP9—bile duct cancer	7.97e-05	8e-05	CbGpPWpGaD
Nicardipine—CYP2C19—liver—bile duct cancer	7.96e-05	0.0218	CbGeAlD
Nicardipine—CYP2C9—Metabolism—PTGS2—bile duct cancer	7.95e-05	7.98e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—bile duct cancer	7.95e-05	7.98e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—IL6—bile duct cancer	7.91e-05	7.94e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—bile duct cancer	7.87e-05	7.9e-05	CbGpPWpGaD
Nicardipine—ADRA1A—liver—bile duct cancer	7.87e-05	0.0215	CbGeAlD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—bile duct cancer	7.85e-05	7.88e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—IL6—bile duct cancer	7.65e-05	7.68e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—IL6—bile duct cancer	7.65e-05	7.68e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—HRAS—bile duct cancer	7.63e-05	7.66e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KRAS—bile duct cancer	7.53e-05	7.56e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KRAS—bile duct cancer	7.51e-05	7.54e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KRAS—bile duct cancer	7.44e-05	7.46e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—bile duct cancer	7.42e-05	7.45e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KRAS—bile duct cancer	7.42e-05	7.44e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—HRAS—bile duct cancer	7.38e-05	7.41e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—HRAS—bile duct cancer	7.38e-05	7.41e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NRAS—bile duct cancer	7.31e-05	7.33e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—IL6—bile duct cancer	7.3e-05	7.33e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HRAS—bile duct cancer	7.1e-05	7.12e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NRAS—bile duct cancer	7.07e-05	7.09e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NRAS—bile duct cancer	7.07e-05	7.09e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—IL6—bile duct cancer	7.07e-05	7.09e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—IL6—bile duct cancer	7.07e-05	7.09e-05	CbGpPWpGaD
Nicardipine—CYP2C8—liver—bile duct cancer	6.95e-05	0.019	CbGeAlD
Nicardipine—ADRA1B—Signaling Pathways—IL6—bile duct cancer	6.79e-05	6.82e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TGFB1—bile duct cancer	6.79e-05	6.81e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—bile duct cancer	6.7e-05	6.72e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—bile duct cancer	6.67e-05	6.7e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—bile duct cancer	6.66e-05	6.68e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—bile duct cancer	6.61e-05	6.63e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—bile duct cancer	6.59e-05	6.62e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TGFB1—bile duct cancer	6.57e-05	6.59e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TGFB1—bile duct cancer	6.57e-05	6.59e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—bile duct cancer	6.44e-05	6.46e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—bile duct cancer	6.44e-05	6.46e-05	CbGpPWpGaD
Nicardipine—CALM2—lymph node—bile duct cancer	6.43e-05	0.0176	CbGeAlD
Nicardipine—CHRM1—Signaling Pathways—HRAS—bile duct cancer	6.4e-05	6.43e-05	CbGpPWpGaD
Nicardipine—CALM1—lymph node—bile duct cancer	6.4e-05	0.0175	CbGeAlD
Nicardipine—CHRM3—Signaling Pathways—HRAS—bile duct cancer	6.38e-05	6.41e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HRAS—bile duct cancer	6.32e-05	6.34e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HRAS—bile duct cancer	6.3e-05	6.33e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KRAS—bile duct cancer	6.29e-05	6.31e-05	CbGpPWpGaD
Nicardipine—CYP3A5—liver—bile duct cancer	6.27e-05	0.0172	CbGeAlD
Nicardipine—CYP2B6—liver—bile duct cancer	6.23e-05	0.0171	CbGeAlD
Nicardipine—CYP2C9—liver—bile duct cancer	6.17e-05	0.0169	CbGeAlD
Nicardipine—CHRM1—Signaling Pathways—IL6—bile duct cancer	6.13e-05	6.15e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—IL6—bile duct cancer	6.11e-05	6.13e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KRAS—bile duct cancer	6.08e-05	6.1e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KRAS—bile duct cancer	6.08e-05	6.1e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—IL6—bile duct cancer	6.05e-05	6.07e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—IL6—bile duct cancer	6.03e-05	6.06e-05	CbGpPWpGaD
Nicardipine—CYP2E1—liver—bile duct cancer	5.85e-05	0.016	CbGeAlD
Nicardipine—CALM3—Signaling Pathways—TP53—bile duct cancer	5.59e-05	5.61e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—bile duct cancer	5.41e-05	5.43e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—bile duct cancer	5.41e-05	5.43e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HRAS—bile duct cancer	5.34e-05	5.36e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—bile duct cancer	5.24e-05	5.26e-05	CbGpPWpGaD
Nicardipine—ABCB1—pancreas—bile duct cancer	5.24e-05	0.0143	CbGeAlD
Nicardipine—CALM1—Signaling Pathways—HRAS—bile duct cancer	5.17e-05	5.19e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HRAS—bile duct cancer	5.17e-05	5.19e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—IL6—bile duct cancer	5.12e-05	5.13e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—IL6—bile duct cancer	4.95e-05	4.97e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—IL6—bile duct cancer	4.95e-05	4.97e-05	CbGpPWpGaD
Nicardipine—CYP3A4—liver—bile duct cancer	4.71e-05	0.0129	CbGeAlD
Nicardipine—CYP2D6—liver—bile duct cancer	4.63e-05	0.0127	CbGeAlD
Nicardipine—ABCB1—liver—bile duct cancer	3.33e-05	0.00912	CbGeAlD
Nicardipine—ABCB1—lymph node—bile duct cancer	2.56e-05	0.00699	CbGeAlD
